GENEVA, Sept. 24 -- ONCOPIA THERAPEUTICS, INC. D/B/A/ SK LIFE SCIENCE LABS filed a patent application (US2026/020172) for “SPIROCYCLIC COMPOUNDS AS CBP/P300 DEGRADERS AND USES THEREOF”. With publication no. WO/2026/198918, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 401/14

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....